Comparison of the effects of remimazolam and propofol on agitation during the awakening period in elderly patients undergoing hip replacement: a clinical, randomized, controlled study

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2023
INTERVENTION: Remimazolam group:Infusion of remimazolam;Propofol group:Infusion of propofol; CONDITION: N/A PRIMARY OUTCOME: Incidence of agitation during the waking period; SECONDARY OUTCOME: Hemodynamic parameters;Adverse reactions during awakening; INCLUSION CRITERIA: 1. Aged 60‐75 years; 2. ASA ?‐? level; 3. BMI 18‐28 kg/m^2; 4. Have independent communication skills.
Epistemonikos ID: 34eaafd709565ad686fc53109f4cb86a76b0b7d1
First added on: Feb 20, 2024